C-56 , 37th Parliament, 2nd session September 30, 2002, to November 12, 2003
An Act to amend the Patent Act and the Food and Drugs Act
Summary
Current status
At consideration in committee in the House of Commons
Latest activity
Second reading and referral to committee on November 7, 2003 (House of Commons)
Progress
House of Commons
End of stage activity
Introduction and first reading, November 6, 2003
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
November 6, 2003 |
End of stage activity
Second reading and referral to committee, November 7, 2003
Chamber sittings
| Sitting date | Debates (Hansard) |
|---|---|
November 7, 2003 |
Sitting 153
Major speeches
Agreed to
(Journals 153)
|
Consideration in committee
No activity
Report stage
Not reached
Third reading
Not reached
First reading
Not reached
Second reading
Not reached
Third reading
Not reached
Details
Recorded votes
House of Commons
There are currently no recorded votes for this bill.
Senate
To view the complete list of standing votes that have taken place in the Senate, please refer to the Votes page of the Senate of Canada website.Speaker's rulings and statements
There are currently no Speaker's rulings and statements.
Major speeches at second reading
House of Commons
| Speech date | Speech | Member of Parliament |
|---|---|---|
| November 7, 2003 | Sponsor’s speech(Sitting 153) | Serge Marcil (Liberal) |
| November 7, 2003 | Response speech(Sitting 153) | James Rajotte (Canadian Alliance) |
| November 7, 2003 | Response speech(Sitting 153) | Paul Crête (Bloc Québécois) |
| November 7, 2003 | Response speech(Sitting 153) | André Bachand (PC) |
| November 7, 2003 | Response speech(Sitting 153) | Alexa McDonough (NDP) |
About
Legislative summary
No legislative summary is available
Similar bills
No similar bills were introduced during previous sessions or Parliaments
From the Library of Parliament
The Library of Parliament’s research publications provide non-partisan, reliable and timely information and analysis on current and emerging issues, legislation and major public policy topics.
Further reading
A war over drugs and patents.
The Economist, 358:43-4
Drug-induced dilemma.
The Economist, 359:59-60
Experts clash over liklely impact of cheap AIDS drugs in Africa.
Wadman, Meredith.
Nature, 410:615-16
In Africa, patents kill.
Shulman, Seth.
Technology review, 104:37
No turning back on cheap AIDS drugs for poor nations, UN vows.
Silversides, Anne.
CMAJ:Canadian Medical Association journal, 169:1067
Out-licensing: a practical approach for improvement of access to medicines in poor countries.
Friedman, Michael A., Henk den Besten and Amir Attaran.
The Lancet, 361:341-44
Protection racket: drugs companies are tightening their hold on Third World markets.
MacKenzie, Debora.
New scientist, 171:18-19
Symptomatic relief: drugs, patents and the WTO.
The Economist, 368:13
The G8 fails global health.
Orbinski, James.
CMAJ:Canadian Medical Association journal, 167:481-2
The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti, Andrea M..
American journal of law and medicine, 27:469-85
The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti, Andrea M..
American journal of law and medicine, 27:469-85